PKI-166, CAS 187724-61-4

Product Description: PKI-166 is a potent, selective and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 0.7 nM[1].

Applications: Cancer-Kinase/protease

Formula: C20H18N4O

References: [1]Bruns CJ, et al. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res. 2000 Jun 1;60(11):2926-35.

CAS Number: 187724-61-4

Molecular Weight: 330.38

Compound Purity: 99.58

Research Area: Cancer

Solubility: DMSO : ≥ 125 mg/mL

Target: EGFR

• SKU: MEXHY-117155-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-117155-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK